Female sexual arousal dysfunction (Q40774): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
A disfunção da excitação sexual da mulher é caracterizada pela ausência ou redução acentuada da resposta à estimulação sexual em mulheres, manifestada por qualquer uma das seguintes situações: 1) Ausência ou redução acentuada da resposta genital, incluindo lubrificação vulvovaginal, ingurgitamento da genitália e sensibilidade da genitália; 2) Ausência ou redução acentuada das respostas não genitais, como endurecimento dos mamilos, rubor da pele, aumento da frequência cardíaca, aumento da pressão arterial e aumento da frequência respiratória; 3) Ausência ou redução acentuada nas sensações de excitação sexual (excitação sexual e prazer sexual) a partir de qualquer tipo de estimulação sexual. A ausência ou redução acentuada na resposta à estimulação sexual ocorre apesar do desejo de atividade sexual e estimulação sexual adequada, (podendo), de forma episódica ou persistente por um período de pelo menos vários meses e associada a sofrimento clinicamente significativo. | |||
| description / en | description / en | ||
Female sexual arousal dysfunction is characterised by absence or marked reduction in response to sexual stimulation in women, as manifested by any of the following: 1) Absence or marked reduction in genital response, including vulvovaginal lubrication, engorgement of the genitalia, and sensitivity of the genitalia; 2) Absence or marked reduction in non-genital responses such as hardening of the nipples, flushing of the skin, increased heart rate, increased blood pressure, and increased respiration rate; 3) Absence or marked reduction in feelings of sexual arousal (sexual excitement and sexual pleasure) from any type of sexual stimulation. The absence or marked reduction in response to sexual stimulation occurs despite the desire for sexual activity and adequate sexual stimulation, has occurred episodically or persistently over a period at least several months, and is associated with clinically significant distress. | |||
Revision as of 06:44, 13 August 2026
Female sexual arousal dysfunction is characterised by absence or marked reduction in response to sexual stimulation in women, as manifested by any of the following: 1) Absence or marked reduction in genital response, including vulvovaginal lubrication, engorgement of the genitalia, and sensitivity of the genitalia; 2) Absence or marked reduction in non-genital responses such as hardening of the nipples, flushing of the skin, increased heart rate, increased blood pressure, and increased respiration rate; 3) Absence or marked reduction in feelings of sexual arousal (sexual excitement and sexual pleasure) from any type of sexual stimulation. The absence or marked reduction in response to sexual stimulation occurs despite the desire for sexual activity and adequate sexual stimulation, has occurred episodically or persistently over a period at least several months, and is associated with clinically significant distress.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | HA01.0 |
||
| English | Female sexual arousal dysfunction |
Female sexual arousal dysfunction is characterised by absence or marked reduction in response to sexual stimulation in women, as manifested by any of the following: 1) Absence or marked reduction in genital response, including vulvovaginal lubrication, engorgement of the genitalia, and sensitivity of the genitalia; 2) Absence or marked reduction in non-genital responses such as hardening of the nipples, flushing of the skin, increased heart rate, increased blood pressure, and increased respiration rate; 3) Absence or marked reduction in feelings of sexual arousal (sexual excitement and sexual pleasure) from any type of sexual stimulation. The absence or marked reduction in response to sexual stimulation occurs despite the desire for sexual activity and adequate sexual stimulation, has occurred episodically or persistently over a period at least several months, and is associated with clinically significant distress. |
